Table 2.
Age range (years) | Age (years) mean (SD) |
Male gender n (%) |
Area of origin n (%) |
ICU admission n (%) |
In-hospital mortality n (%) |
Co-morbiditya n (%) |
---|---|---|---|---|---|---|
0–20 | 18.6 (0.5) | 2/3 (66.7) | LA: 3/3 (100) | 0 | 0 | 1/3 (33) |
21–40 | 34.6 (5.2) | 32/55 (58.2) | LA: 50/55 (90.9) | 9/55 (16.4) | 0 | 11/55 (20) |
AS: 3/55 (5.4) | ||||||
AFR: 2/55 (3.6) | ||||||
41–60 | 51.4 (5.4) | 134/224 (59.8) | LA: 206/224 (92) | 42/224 (18.7) | 12/224 (5.3) | 85/224 (37.9) |
AS: 11/224 (4.9) | ||||||
AFR: 7/224 (3.1) | ||||||
61–80 | 68.3 (5.4) | 49/94 (52.1) | LA: 84/94 (89.4) | 20/94 (21.2) | 21/94 (22.3) | 61/94 (64.9) |
AS: 5/94 (5.3) | ||||||
AFR: 5/94 (5.3) | ||||||
81–100 | 87.2 (3.8) | 6/13 (46.2) | LA: 11/13 (84.6) | 0 | 7/13 (53.8) | 12/13 (92.3) |
AFR: 2/13 (15.4) |
Abbreviations: AFR, Africa; AS, Asia; COVID-19, coronavirus disease 2019; ICU, intensive care unit; LA, Latin America.
Presence of at least one of the following: hypertension, diabetes mellitus, chronic pulmonary disease, chronic renal disease, cardiovascular disease, neoplasia or immunosuppression.